SCHEMBL1773862

SCHEMBL1773862

CO[C@@]1(C)CC[C@@]23C[C@@H]1C(C)(C)[C@@H]2CC[C@H]3C

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.65
▸ ALDH1A1 P00352 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ THRB P10828 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ CYP17A1 P05093 3/20 0.49
▸ CYP19A1 P11511 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873204 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL32678404 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL14841540 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL8738678 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL19718040 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL18138230 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL24534431 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL19718041 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL17836881 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1
SCHEMBL3502857 1.00 ALOX15 (0.65) ALOX15ALDH1A1LMNATHRBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 — — WO claimed
WO-2025045354-A1 A FRAGRANCE TABLET SYMRISE AG (DE) 2025-03-06 — — WO claimed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 — — WO claimed
EP-4262735-A1 TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIALS The Procter & Gamble Company (US) 2023-10-25 — — EP claimed
CN-116917450-A Treatment composition comprising plant rosin material 宝洁公司 2023-10-20 — — CN claimed
US-20220195348-A1 TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIAL AND CERTAIN PERFUME RAW MATERIALS THE PROCTER & GAMBLE COMPANY 2022-06-23 — — US claimed
WO-2022133426-A1 TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2022-06-23 — — WO claimed
EP-1894603-B1 Encapsulation of bulky fragrance molecules TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 — — EP claimed
EP-4713129-A1 ORGANOSILICON-BASED MICROCAPSULES Firmenich SA (CH) 2026-03-25 — — EP disclosed
US-12577511-B2 Agent containing emulsifier and microcapsules HENKEL AG & CO. KGAA (DE) 2026-03-17 — — US disclosed
WO-2026046686-A1 EVAPORATING MICROEMULSIONS SYMRISE AG (DE) 2026-03-05 — — WO disclosed
WO-2026046506-A1 EVAPORATING MICROEMULSIONS SYMRISE AG (DE) 2026-03-05 — — WO disclosed
WO-2026041220-A1 FRAGRANCES WITH NEW ODOR MIXTURES AND USE THEREOF IN PERFUMERY SYMRISE AG (DE) 2026-02-26 — — WO disclosed
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL SYMRISE AG (DE) 2026-02-19 — — US disclosed
CN-100503798-C Household product TAKASAGO PERFUMERY CO LTD (JP) 2009-06-24 — — CN disclosed
US-20080176780-A1 ENCAPSULATION OF BULKY FRAGRANCE MOLECULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2008-07-24 — — US disclosed
EP-1894603-A1 Encapsulation of bulky fragrance molecules Takasago International Corporation (JP) 2008-03-05 — — EP disclosed
EP-1632559-B1 Household products, including inside air-care products. TAKASAGO PERFUMERY CO LTD (JP) 2007-08-22 — — EP disclosed
US-20060035795-A1 Household products TAKASAGO INTERNATIONAL CORPORATION 2006-02-16 — — US disclosed
CN-1730637-A Household product TAKASAGO PERFUMERY CO LTD (JP) 2006-02-08 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577511-B2 Agent containing emulsifier and microcapsules LIPA, CUTA, MGLL ALOX15 311/4885ALDH1A1 1582/4885LMNA 1045/4885
US-20260047994-A1 AN ACTIVE COMPOSITION COMPRISING RETINOL RBP4, LRAT, RARB ALOX15 438/4885ALDH1A1 156/4885LMNA 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback